Abstract | INTRODUCTION: AIM: METHODS: A review of the literature on the topic was performed. RESULTS: In osteoarthritis, reports with a high level of evidence state that the efficacy of IA injections of CS is controversial. In haemophilic arthropathy, some low-level evidence reports seem to indicate that short-term pain alleviation can be achieved. CONCLUSIONS: Considering that pain relief after IA injections of CS is controversial and that the cost of the haematologic treatment required to perform the procedure is high in haemophilic arthropathy, we do not recommend the routine use of CS IS injections in haemophilia. Moreover, point of care (POC) ultrasound (US)-guided injections are not advised, because the injection procedure is so simple that the use of POC-US will unnecessarily prolong the duration of the procedure.
|
Authors | E Carlos Rodriguez-Merchan |
Journal | Hospital practice (1995)
(Hosp Pract (1995))
Vol. 46
Issue 1
Pg. 1-4
(Feb 2018)
ISSN: 2154-8331 [Print] England |
PMID | 29172843
(Publication Type: Journal Article, Review)
|
Chemical References |
- Adrenal Cortex Hormones
- Anti-Inflammatory Agents
|
Topics |
- Adrenal Cortex Hormones
(administration & dosage, therapeutic use)
- Anti-Inflammatory Agents
(administration & dosage, therapeutic use)
- Hemarthrosis
(complications, drug therapy)
- Humans
- Injections, Intra-Articular
- Osteoarthritis
(drug therapy)
- Pain
(drug therapy, etiology)
- Ultrasonography, Interventional
|